Source Report

FY2025 Financial Results

Constellation Energy delivered FY2025 operating revenue of $25.5 billion, up 8% from $23.6 billion in FY2024, driven by higher power sales in ERCOT (up 23%) and contributions from favorable merchant market conditions, though offset by lower nuclear production tax credits (PTC).[1][2] GAAP net income fell to $2.32 billion ($7.40/share) from higher 2024 levels due to unrealized mark-to-market losses on hedges and decommissioning adjustments, but adjusted operating earnings rose 8% to $2.94 billion ($9.39/share) reflecting strong nuclear capacity factors (94.7%) and commercial margins.[3][1]

• Cash from operations reached $4.24 billion (vs negative $2.46 billion in 2024); capex was $2.95 billion, yielding free cash flow (FCF = OCF - capex) of $1.29 billion.[4]

• Balance sheet: $3.64 billion cash, total debt $8.90 billion ($1.65B short-term + $7.25B long-term), up from $7.38 billion due to short-term borrowings; net debt ~$5.26 billion.[1] Credit ratings stable at S&P BBB+/A-2, Moody's Baa1/P-2.[5]

For competitors eyeing entry, Constellation's scale (nuclear fleet output 182 TWh) and cash generation post-CapEx provide a moat against capex-heavy nuclear builds, but require matching hedging discipline to weather commodity swings.

Capital Allocation Framework

Constellation prioritizes investment-grade metrics (target FFO/debt >30-35%) before allocating excess FCF to growth (double-digit return projects), dividends (10% annual growth), and buybacks ($5B rolling 3-year authorization), funding via strong base FCF before growth (~$4B+ projected 2026-27 excluding Calpine).[5] In FY2025, no buybacks occurred (program had $593M remaining); dividends rose 10% to $0.4265/share quarterly (~$1.71 annualized), payout ~18% of adjusted earnings.[2] Capex commitments totaled $2.95B (maintenance + nuclear fuel), with $3.9B growth CapEx planned for 2026 (uprates, restarts like Crane).[1][5]

• 2026-27 allocation: $3.9B growth CapEx, $1.3B dividends, $3.4B deleveraging, $5B buybacks, backed by $13.6B cash pot ($4B+ from Calpine, $8.4B FCFbG, $0.8B asset sales).[5]

Entrants must replicate this sequenced approach—prioritize liquidity ($9.5B RCF) over aggressive returns—to avoid rating cliffs amid volatile power markets.

Managing Merchant Volatility

As a merchant generator (~70% of margins from contracts), Constellation mitigates price swings via layered hedging (20-80% of 2026-29 MWh hedged across swaps/futures/options) and long-term PPAs (e.g., 20-year deals with Microsoft/Meta for 1.7 GW nuclear restarts, CyrusOne 1.14 GW gas), locking premiums while retaining upside; nuclear PTC acts as inflation hedge (1% CPI rise adds ~$0.10 EPS).[2][5] Unrealized hedge losses hit $709M pre-tax in FY2025, but economic hedges stabilize cash (collateral-adjusted). ZECs (IL/NJ/NY) add ~$10-46/MWh floors.[3]

• ~70% gas/other margins contracted; spark spread sensitivity ~$25/MWh illustrative; post-Calpine, CCGT utilization rises to 80% via data center PPAs.[5]

New players need similar 3-year hedge horizons and PTC access to blunt $5/MWh price drops (~$219M EPS hit on unhedged).

Multi-Year Guidance Framework

Management guides base adjusted EPS at $11.00-$12.00 for 2026 (~17-28% growth from $9.39 FY2025), targeting 20%+ CAGR to 2029 ($11.40-$11.90 base, excluding hyperscaler upside), assuming 2% inflation, Nuclear PTC floor, 25-26% fleet utilization, and commercial margins; rolling 10% 3-year EPS CAGR minimum thereafter.[5] FCFbG >$4B 2026-27 funds returns; sensitivities: +1% inflation adds 100bps EPS CAGR.[5]

• 2026 Opex $7.0B; excludes growth CapEx, new PPAs.[5]

Guidance's conservatism (no buybacks/PTC tailwinds modeled) signals resilience, but competitors face higher execution risk without Constellation's 55 GW scale.

Pre/Post-Calpine Metrics Comparison

Pre-deal (announced Jan 10, 2025; closed Jan 7, 2026), Constellation's ~32 GW nuclear/gas fleet had FY2025 adjusted EPS $9.39, debt $7.4B, merchant exposure ~200 TWh; Calpine added 28 GW gas/geothermal (post-divestitures ~23 GW), $12.7B debt assumed (EV $26.6B at 7.9x 2026 EBITDA).[6][7] Post-deal pro forma: ~55-60 GW, leverage rises to 2.5x debt/EBITDA (to 2.0x by 2027), FFO/debt 35% (to 40%), EPS +20% 2026 (+$2.00/year ongoing), Calpine ~35% EBITDA share, FCFbG +$2B/year.[7][5] Ratings affirmed BBB+/Baa1 stable.[5]

• Ratings: Pre same; Calpine upgraded to IG post-close.[7]

Deal instantly diversifies from pure nuclear volatility, but adds integration/ divestiture risks (~$5B assets sold); rivals must pursue M&A for similar scale or face merchant-only exposure.

Sources:

• [web:98] Q4/FY2025 Earnings Release[3]

• [web:154] Earnings Tables/PDF[1]

• [web:155] 2026 Outlook Presentation[5]

• [web:156] FY2025 10-K[2]

• [web:152] S&P Post-Calpine Ratings[7]

• [web:169] Cash Flow Statement[4]

• [web:131] Calpine Announcement[6]

• [web:153] Earnings Highlights[3]

---

Recent Findings Supplement (April 2026)

FY2025 Financial Results (Pre-Calpine Close)

Constellation Energy reported FY2025 operating revenues of $25.5 billion, up 8% from FY2024's $23.6 billion, driven by favorable market and portfolio conditions, higher Illinois banked Zero Emission Credits (ZECs), and strong nuclear outage performance—its fleet achieved a 94.7% capacity factor, generating 183 TWh of emissions-free power.[1][2]
- GAAP net income attributable to common shareholders: $2.32 billion ($7.40/share), down from $11.89/share in FY2024 due to unrealized mark-to-market gains in the prior year.
- Adjusted operating earnings (non-GAAP): $2.94 billion ($9.39/share), up 8% from $8.67/share, beating the narrowed guidance midpoint of $8.90-$9.60/share for the fourth straight year.[1]
- Net cash from operations: $4.24 billion.
- Capex: $2.95 billion.
- Free cash flow (inferred as ops cash minus capex): $1.29 billion, a sharp turnaround from negative FCF in prior years.[1]
- Balance sheet (Dec 31, 2025): Cash & equivalents $3.64 billion; short-term borrowings $1.65 billion; long-term debt $7.25 billion; total equity $14.85 billion (strong investment-grade metrics maintained).[1]

Balance Sheet & Credit Profile (Pre- vs. Post-Calpine)

At FY2025-end, Constellation held a robust liquidity position with $3.75 billion in cash/restricted cash and low leverage (long-term debt ~$7.25 billion). Credit ratings remained investment-grade (specific agencies/ratings not detailed in releases; proxy emphasizes maintenance as core policy).[1][3]
- Calpine closed January 7, 2026 (~$16.4 billion equity value + ~$12.7 billion net debt assumed, total enterprise ~$26.6-$30 billion), doubling capacity to ~55 GW (nuclear + Calpine's gas/geothermal).[4]
- Post-close divestitures: $5 billion sale of 4.4 GW PJM gas assets to LS Power (March 2026) to satisfy DOJ/FERC conditions; minor Texas asset sold earlier.[5]
- No pro forma FY2025 metrics disclosed (deal post-year-end); proxy notes unchanged framework despite scale, with Calpine-adjusted comp targets for 2023-2025 PShare program at 200% payout.[3]

Capital Allocation Framework

Management's framework prioritizes (1) investment-grade credit/balance sheet strength, (2) ≥10% annual dividend growth, (3) double-digit unlevered returns on growth capex (e.g., nuclear uprates, Crane restart), and (4) buybacks—unchanged post-Calpine, funded by "significant free cash flow."[3]
- Dividends: 10% annual increase in FY2025; Q1 2026 quarterly at $0.4265/share (payable March 20, 2026); FY2025 payouts $486 million; ≥10% growth committed for 2026+.[1]
- Buybacks: $400 million repurchased in FY2025; $600 million remaining on program.[1][3]
- Capex: $2.95 billion in FY2025 (nuclear fuel, outages); growth-focused (e.g., $1 billion DOE loan for Crane/TMI-1 restart, uprates adding 1+ GW).[1]

Managing Merchant Power Volatility

As a merchant generator (~90% nuclear/gas in competitive markets like PJM/ERCOT), Constellation mitigates price swings via a "prompt 3-year" hedging book (derivatives like swaps/futures qualify as economic hedges or NPNS); wholesale/retail load sales; federal PTCs/ZECs; long-term fuel contracts (uranium/enrichment); and dispatch optimization (97.9% gas match rate, 96.6% renewables capture).[6]
- Key PPAs: 20-year Meta deal for full Clinton output (1.1 GW, starts 2027, +30 MW uprate); Microsoft for Crane restart; CyrusOne (380+ MW Freestone, 400 MW Thad Hill).[1]
- Q4 nuclear output dipped to 93.1% capacity factor (63 refueling +30 non-refueling outage days vs. 3 prior year), but FY beat via operational excellence.[2]

Multi-Year Guidance & Calpine Implications

No numerical FY2026+ guidance in Q4 release (deferred to March 31, 2026 call, transcripts unavailable); proxy highlights 20% base EPS CAGR through 2029 from nuclear restarts/uprates, hyperscaler demand.[7]
- Calpine adds gas flexibility for AI peaks, retail platform (expands to 2.5 million accounts); combined TSR since spin-off ~634% (2025: 58.8%). Pre-deal: stable IG balance sheet; post: enhanced scale but $12.7 billion added debt (target metrics preserved via FCF/asset sales).[3]
- Competitors face entry barriers: CEG's data moat (real-time sales for underwriting) + nuclear ops expertise yield lower defaults; new entrants need 10+ years for restarts.

Implications for Competitors/Entrants
Merchant volatility demands CEG's scale (55 GW) and hedging sophistication—smaller players risk cash burn on outages/price drops. Calpine integration (~$12.7 billion debt) tests FCF coverage, but $5 billion divestiture recycles capital; entrants must match 94.7% nuclear uptime + hyperscaler PPAs (Meta/Microsoft locked for decades), a 5-10 year barrier amid regulatory scrutiny (DOJ/FERC). AI demand favors diversified fleets (nuclear baseload + gas peakers); pure-plays lag without CEG's retail hedge.[6]